Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (28467)	3/3/1999 6:32:00 PM
From: Henry Niman	Read Replies (2) of 32384

LGND's first alliance was with PFE and the royalty rate is the lowest. All other royalty rates are double digits. LGND has 4 SERMs in the clinic and one that is in pre-clinical testing TSE424 (AHP) is a SERM in the clinic for osteoporosis ERA-923 (AHP) is a SERM in the clinic for breast cancer Droloxifene (PFE) is a SERM in the clinic for osteoporosis and prevention of breast cancer CP-366,156 (PFE) is a SERM in the clinic for osteoporosis and may be better than Droloxifene 2nd Generation SERM (LLY) is research program with LLY for breast cancer Idoxifene (SBH) is a SERM that LGND is not involved with, but not clear that it is advancing to Phase III

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next